Inventor · disambiguated record
Catherine Ettinger
Also filed as: ETTINGER CATHERINE · ETTINGER CATHERINE RACHEL
8 granted patents·2 pending applications·62 citations·filing 2004–2024
84Inventor score
Files withBOSTON PHARMACEUTICALS INC4HORIZON THERAPEUTICS IRELAND DAC2US HEALTH2ETTINGER CATHERINE RACHEL1VIELA BIO INC1
Top patents by PatentIndex Score
10 records- 0195US7378276B2Method of inducing memory B cell development and terminal differentiationUS HEALTH·Filed 2005·Granted May 27, 2008·41 cites·4 claims
- 0289US8247228B2Method of inducing memory B cell development and terminal differentiationETTINGER CATHERINE RACHEL·Filed 2008·Granted Aug 21, 2012·15 cites·8 claims
- 0383US2025122276A1Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 0480US11512127B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesVIELA BIO INC·Filed 2019·Granted Nov 29, 2022·2 cites·21 claims
- 0578US12209123B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2022·Granted Jan 28, 2025·0 cites·19 claims
- 0675US2023201346A1Binding molecules specific for il-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0773US10022443B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 0868US7993919B2Method of inducing memory B cell development and terminal differentiationUS HEALTH·Filed 2004·Granted Aug 9, 2011·3 cites·7 claims
- 0967US11529415B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·0 cites·14 claims
- 1067US10588969B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →